Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
Journal of Experimental & Clinical Cancer Research (2015) Vol. 34, Iss. 1
Open Access | Times Cited: 594

Showing 26-50 of 594 citing articles:

Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
Giuseppina Comito, Anthony Iscaro, Marina Bacci, et al.
Oncogene (2019) Vol. 38, Iss. 19, pp. 3681-3695
Closed Access | Times Cited: 179
The Id-protein family in developmental and cancer-associated pathways
Cornelia Roschger, Chiara Cabrele
Cell Communication and Signaling (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 176
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
An‐Na Chen, Yan Luo, Yuhan Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 176
Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts
Chong Zhang, Xiangyu Wang, Peng Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 171
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
Jiao Feng, Weiqi Dai, Yuqing Mao, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 168
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Katherine G. Roth, Isa Mambetsariev, Prakash Kulkarni, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 1, pp. 119-134
Open Access | Times Cited: 165
Autophagy in the physiological endometrium and cancer
Laura Devis, Núria Eritja, Meredith Leigh Davis, et al.
Autophagy (2020) Vol. 17, Iss. 5, pp. 1077-1095
Open Access | Times Cited: 161
Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
Liwen Wang, Yihao Liu, Yuting Dai, et al.
Gut (2022) Vol. 72, Iss. 5, pp. 958-971
Open Access | Times Cited: 154
The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Jinguan Lin, Longzheng Xia, Jiaxin Liang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 149
Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
Shan Wang, Jialei Fu, Huifeng Hao, et al.
Pharmacological Research (2021) Vol. 170, pp. 105728-105728
Closed Access | Times Cited: 140
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 130
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni, Xiaoting Zhou, Jia Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 109
Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 102
Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
Yi Zhang, Qiong Li, Zhao Huang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4568-4568
Open Access | Times Cited: 88
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 81
Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy
Qihang Yuan, Dawei Deng, Pan Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 80
Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer
Babak Arjmand, Shayesteh Kokabi Hamidpour, Akram Tayanloo-Beik, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 79
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia, Hao Zhang, Haofeng Lu, et al.
Cancer Communications (2023) Vol. 43, Iss. 3, pp. 338-364
Open Access | Times Cited: 77
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 71
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63
Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2023) Vol. 559, pp. 216119-216119
Closed Access | Times Cited: 61
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development
Kai Liang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 52
Metabolic reprogramming in skin wound healing
Zitong Wang, Feng Zhao, Chengcheng Xu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 35
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 24
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2

Scroll to top